CAR-T Companies and Organizations

 

6 Organization(s)

Allogene Therapeutics

Business Area(s): 
Description: 

Allogene Therapeutics is a biotechnology company developing allogeneic chimeric antigen receptor T-cell (CAR T) therapy directed at blood cancers and solid tumors.

Cell Medica

Business Area(s): 
Description: 

Cell Medica develops therapeutics based on cellular immunotherapy with the aim of improving the treatment of cancer and immune reconstitution following hematopoietic stem cell transplant.

Legend Biotech

Business Area(s): 
Description: 

Legend Biotech's first product candidate, LCAR-B38M, is a B cell maturation antigen (BCMA)-directed chimeric antigen receptor T (CAR-T) cell therapy. The novel dual-epitope design of the BCMA ...

Mustang Bio

Business Area(s): 
Description: 

Mustang Bio, Inc., a subsidiary of Fortress Biotech, Inc., is a clinical‐stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products ...

Precision BioSciences

Business Area(s): 
Description: 

The backbone of the ARCUS technology is the ARC Nuclease – a fully synthetic enzyme that is very similar to a homing endonuclease but is modified to be a better starting point for the development ...

Don't see an employer? Please fill out the form